Additions to Schedules in Ss. 961.14, 961.16, 961.18, 961.20 and 961.22, Stats.

CSB 2.87 Addition of embutramide to schedule III. Section 961.18 (3) (bm), Stats., is created to read: 961.18 (3) (bm) Embutramide; History: cr. Affirmative action order under s. 961.11 (4), Stats., Register July 2021 No. 787, eff. 7-19-21; correction made under s. 35.17, Stats.,…

CSB 2.88 Addition of lacosamide to schedule V. Section 961.22 (10), Stats., is created to read: 961.22 (10) Lacosamide. History: cr. Affirmative action order under s. 961.11 (4), Stats., Register July

CSB 2.89 Addition of perampanel to schedule III. Section 961.18 (3) (fm), Stats., is created to read: 961.18 (3) (fm) Perampanel. History: cr. Affirmative action order under s. 961.11 (4), Stats., Register July 2021 No. 787, eff. 7-19-21; correction made under s. 35.17, Stats., R…

CSB 2.90 Transfer of 1-phenylcyclohexylamine and 1-piperidinocyclohexanecarbonitrile, immediate precursors to phencyclidine, also known as PCP, from schedule I to schedule II. Section 961.16 (8) (c), Stats., is created to read: 961.16 (8) (c) Immediate precursors to phencyclidine…

CSB 2.91 Addition of 4,4’-Dimethylaminorex to schedule I. Section 961.14 (7) (cm), Stats., is created to read: 961.14 (7) (cm) 4,4’-Dimethylaminorex. 7-1-23.

CSB 2.92 Addition of thirty-five (35) Anabolic Steroids to schedule III. Section 961.18 (7), Stats., is repealed and recreated to read: 961.18 (7) ANABOLIC STEROIDS. Unless specifically excepted or listed in another schedule, any material, compound, mixture, or preparation contai…

CSB 2.93 Addition of Daridorexant to schedule IV. Section 961.20 (2) (cpm), Stats., is created to read: 961.20 (2) (cpm) Daridorexant; History: cr. Affirmative action order under s. 961.11 (4), Stats., Register August 2022 No. 800, eff. 7-25-22; correction made under s. 35.17, St…

CSB 2.94 Addition of seven (7) synthetic benzimidazole-opioid substances to schedule I. (1) Section 961.14 (2) (mm) and (pe), Stats., are renumbered to 961.14 (2) (xm) 3. and 5. and amended to read: 961.14 (2) (xm) 3. Etonitazene (2-(2-(4-ethoxybenzyl)-5-nitro-1H-benzimidazol1-yl…

CSB 2.95 Addition of Ganaxolone to schedule V. Section 961.22 (11), Stats., is created to read: 961.22 (11) GANAXOLONE. Ganaxolone. History: cr. Affirmative action order under s. 961.11 (4), Stats., Register August 2022 No. 800, eff. 7-25-22; (title) created under s. 13.92 (4) (b…

CSB 2.96 Addition of Amineptine to schedule I. Section 961.14 (7) (r), Stats., is created to read: 961.14 (7) (r) 7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid, commonly known as Amineptine. History: cr. Affirmative action order under s. 961.11 (4), Stats…

CSB 2.97 Addition of Zipeprol to schedule I. Section 961.14 (2) (zm), Stats., is created to read: 961.14 (2) (zm) Zipeprol (1-methoxy-3-[4-(2-methoxy-2-phenylethyl)piperazin1-yl]-1-phenylpropan-2-ol). History: cr. Affirmative action order under s. 961.11 (4), Stats., Register Mar…

CSB 2.98 Excluding [18F]FP-CIT from schedule II. Section 961.16 (2) (b), Stats., is amended to read: 961.16 (2) (b) Coca leaves and any salt, compound, derivative, or preparation of coca leaves. Decocainized coca leaves or extractions which do not contain cocaine or ecgonine are …

CSB 2.99 Addition of Mesocarb to schedule I. Section 961.14 (7) (s), Stats., is created to read: the chapter was last published.